-
MB-101 Receives FDA Orphan Drug Designation for Astrocytoma and Glioblastoma
08 Jul 2025 19:48 GMT
… with recurrent diffuse and anaplastic astrocytoma and glioblastoma.1
“We are … recurrent glioblastoma and high-grade astrocytomas. Our novel therapeutic strategy, combining … CAR T-cells) to treat astrocytomas and glioblastoma. News release. July …
-
FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas
07 Jul 2025 22:19 GMT
… treatment of recurrent diffuse and astrocytomas (anaplastic astrocytoma) and glioblastoma (GBM), … recurrent GBM and high-grade astrocytomas.
Litchman continued, “This progress … recurrent glioblastoma and high-grade astrocytomas will depend on securing …
-
Dr Colman on Outcomes With Eflornithine in Grade 3 Anaplastic Astrocytoma
11 Feb 2025 00:17 GMT
… the current grade 3 astrocytoma population—the IDH-mutant, … -mutant, grade 3 anaplastic astrocytoma.
The intent-to-treat … WHO) definition of anaplastic astrocytoma evolved as the study … defined WHO 2021 anaplastic astrocytoma diagnostic criteria.
The final …
-
… a six-year battle with astrocytoma, a type of brain tumor …
16 Jan 2025 12:22 GMT
In April 2024, 12-year-old Frankie Knowles passed away after a six-year battle with astrocytoma, a type of brain tumor. But even after his death, Frankie's life continues to officer inspiration to those who knew and loved him.
-
TQB-3454 by Chia Tai Tianqing Pharmaceutical Group for Astrocytoma: Likelihood of Approval
06 Jan 2025 02:39 GMT
… leukemia (AML), advanced biliary carcinoma, astrocytoma and myelodysplastic syndrome (MDS). The …
-
Dr Lukas on Survival Outcomes With Eflornithine in IDH-Mutant Anaplastic Astrocytoma
23 Nov 2024 03:57 GMT
… with recurrent IDH-mutant anaplastic astrocytoma per 2021 World Health Organization …
-
Combination of Eflornithine and Lomustine Demonstrates Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma, IDH Mutant Grade 3
22 Nov 2024 16:00 GMT
… grade 3 IDH mutant astrocytoma who have progressed after … alone in patients with anaplastic astrocytoma that recurs after surgery, … grade 3 IDH mutant astrocytoma, clinically meaningful improvements in … with recurrent grade 3 astrocytoma in the STELLAR study …
-
FDA Approves IDH1/2+ Companion Diagnostic for Vorasidenib in Grade 2 Astrocytoma or Oligodendroglioma
21 Oct 2024 15:46 GMT
… confirmed grade 2 oligodendroglioma or astrocytoma per WHO 2016 criteria with … approves vorasidenib for grade 2 astrocytoma or oligodendroglioma with a susceptible … ;fda-approves-vorasidenib-grade-2-astrocytoma-or-oligodendroglioma-susceptible-idh1-or …
-
FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma
10 Oct 2024 18:51 GMT
… with IDH-positive grade 2 astrocytoma or oligodendroglioma. Dr Taylor is … of age with grade 2 astrocytoma or oligodendroglioma harboring susceptible IDH1 … where vorasidenib fits into the astrocytoma or oligodendroglioma treatment paradigms.
___ …
-
Voranigo for Astrocytoma or Oligodendroglioma an ‘Important Step Forward’
19 Aug 2024 15:35 GMT
… slow-growing grade 2 astrocytoma or oligodendroglioma with a … of gliomas, such as astrocytoma and oligodendroglioma, are types … cells in the brain. Astrocytomas develop in children or … IDH-mutant low-grade astrocytoma and oligodendroglioma, Holdhoff explained …
About
© 1995-2025